Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Liabilities and Shareholders Equity (2016 - 2025)

Skinvisible (SKVI) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $127567.0 as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 19.37% to $127567.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $554119.0 through Dec 2025, down 11.1% year-over-year, with the annual reading at $127567.0 for FY2025, 19.37% down from the prior year.
  • Liabilities and Shareholders Equity hit $127567.0 in Q4 2025 for Skinvisible, down from $133623.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $320590.0 in Q2 2022 to a low of $127567.0 in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $190014.5 across 5 years, with a median of $176167.0 in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 38.91% in 2022 and later crashed 38.76% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $227299.0 in 2021, then increased by 8.58% to $246793.0 in 2022, then tumbled by 34.01% to $162869.0 in 2023, then decreased by 2.86% to $158217.0 in 2024, then decreased by 19.37% to $127567.0 in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SKVI at $127567.0 in Q4 2025, $133623.0 in Q3 2025, and $143375.0 in Q2 2025.